MedTrace Logo

Efficacy of Rezum® in Reducing Prostate Volume

NCT06315062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 289

Last updated 2024-03-18

No results posted yet for this study

Summary

This study aimed to assess the efficacy of Rezum® water vapor therapy in reducing prostate volume in patients aged 40 years or older with Benign Prostate Hyperplasia (BPH) at UNIBE Hospital in Costa Rica. A retrospective analysis will be conducted on 289 patient records, focusing on prostate volume, International Prostate Symptom Score (IPSS), and urinary flow rate. Statistical analyses included two-sample mean comparisons, effect size estimation, and linear regression.

Conditions

  • Benign Hyperplasia of Prostate

Sponsors & Collaborators

  • Urología Costa Rica

    lead OTHER

Principal Investigators

  • Mario González Salas, Dr. · Hospital UNIBE

  • Milena Castro Mora, PhD. · Universidad de Costa Rica

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Costa Rica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06315062 on ClinicalTrials.gov